Giovanna Pegolo
Psychiatry · Pasadena, CANPI 1740390293
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 413 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 413 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Bausch Health US, LLC$1K
- Lundbeck LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$832
- Otsuka America Pharmaceutical, Inc.$761
- plus $2K from 4 others
What the payments were for
- Food & beverage$9,191100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 50 | $1,620 |
| AbbVie(2 entities) | 88 | $1,532 |
| Bausch Health US, LLC | 64 | $1,281 |
| Lundbeck LLC | 54 | $1,152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $832 |
| Otsuka America Pharmaceutical, Inc. | 36 | $761 |
| Alkermes, Inc. | 29 | $618 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $523 |
| Vanda Pharmaceuticals Inc. | 19 | $515 |
| Sunovion Pharmaceuticals Inc. | 20 | $377 |
How this compares
$9,211 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 22 | $681 |
| Bupropion Hcl SrBupropion Hcl | 34 | $499 |
| Aripiprazole | 14 | $325 |
| Lorazepam | 32 | $234 |
| Escitalopram Oxalate | 21 | $223 |
| Vilazodone Hcl | 11 | $185 |
| Alprazolam | 29 | $144 |
| Citalopram HbrCitalopram Hydrobromide | 16 | $128 |
| Fluoxetine Hcl | 12 | $125 |
| Sertraline Hcl | 20 | $115 |
| Clonazepam | 16 | $82 |
| Trazodone Hcl | 22 | $72 |
| Zolpidem Tartrate | 21 | $53 |
| Bupropion Hcl | 12 | $43 |
| Diazepam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Pasadena
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.